AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company, stands at a critical juncture as it navigates the loss of ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

Guggenheim analyst Vamil Divan lowered the firm’s price target on AbbVie (ABBV) to $212 from $221 and keeps a Buy rating on the shares. The ...

The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services, announced the selection of 15 additional ...

Guggenheim Securities adjusted its financial outlook for shares of AbbVie Inc . (NYSE:ABBV), reducing the price target to $212 from the previous $221, while still recommending a Buy rating for the ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

Seven-Market Drug Forecast Analysis - Update" report has been added to ResearchAndMarkets.com's offering. Market Growth Driven by Aging Populations and Innovative TherapiesThe global glaucoma market ...

Two years after it was first proposed and a year after it officially launched, the pharma-backed AMR Action Fund has made its first investments in companies trying to tackle the pressing problem ...

She admitted using pharma company logos – including Pfizer – on Theranos documents sent to investors, even though they had not endorsed the technology. She also attempted to place the blame on ...

Teva Pharmaceutical Industries Ltd. ADR-0.51% $24.5B ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 27,497.06 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...